This is a 2-part study evaluating ATV-1601 in participants with moderate to severe HHT. Part 1 is a randomized, double-blind, placebo-controlled study evaluati…

Hereditary Hemorrhagic Telangiectasia (HHT)Osler Weber Rendu Disease

~Estimated

~$500 – $10,500

Actual pay is set by the research site.

Atavistik Bio, IncNCT07601425

Phase 1

A Phase I Trial of TOR-582, a Topical Sirolimus-based Treatment for Epistaxis in Adults With Hereditary Hemorrhagic Telangiectasia

People with hereditary hemorrhagic telangiectasia (HHT) often experience frequent and severe nosebleeds that can disrupt daily life and lead to anemia, medical…

Hereditary Hemorrhagic Telangiectasia (HHT)Epistaxis

~Estimated

~$150 – $3,000

Actual pay is set by the research site.

Columbia UniversityNCT07667413